We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?

XoZymes replaces traditional chemical production methods with an approach that integrates widely available feedstocks like sugar and biomass with advanced enzymes engineered to thrive outside living ...

A new study by Silent Spring Institute and University of California, Berkeley shows how laws that promote greater ...

A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...

Brings together Tabshield ready-to-use film coating systems and ReadiLYCOAT plant-based ready-to-use coating systems.

Nutriband Inc. through its wholly own subsidiary Pocono Pharma engages in the production of multiple products including AI Tape, which is designed to combine many of the traditional benefits of ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, was recently granted U.S. patent US 12,186,299 dated Jan. 7, 2025, Compositions And Methods For Treating ...

South Korean pharmaceutical and biotechnology companies are on edge as U.S. President Donald Trump signals the introduction ...

One might think that a pharmaceutical ingredients company that boasts clients in 80 countries, certification from several ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...